Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck

EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasis of the cancer cells. Nimotuzumab is an engineered, intermediate affinity anti-EGFR antibody, that apart from other drugs in its class, is very safe and does not cause hypomagnesemia or grade 3–4 cutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Crombet Ramos, Tania, Mestre Fernández, Braulio, Mazorra Herrera, Zaima, Iznaga Escobar, Normando E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266975/
https://www.ncbi.nlm.nih.gov/pubmed/32537431
http://dx.doi.org/10.3389/fonc.2020.00817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266975/
https://www.ncbi.nlm.nih.gov/pubmed/32537431
http://dx.doi.org/10.3389/fonc.2020.00817

Ejemplares similares